Alberto Gil-Jimenez

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

Nature communications

Nature medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Netherlands Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Netherlands Cancer Institute

Netherlands

PhD student :: Molecular Carcinogenesis

Publications

Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, Iris M Seignette, Jan-Jaap J Mellema, Maartje Alkemade, Alberto Gil-Jimenez, Dennis Peters, Wim Brugman, Chantal F Stockem, Erik Hooijberg, Annegien Broeks, Bas W G van Rhijn, Laura S Mertens, Antoine G Van der Heijden, Niven Mehra, Maurits L van Montfoort, Lodewyk F A Wessels, Daniel J Vis, Michiel S Van Der Heijden
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos, Yoni Lubeck, Maurits L van Montfoort, Dennis Peters, Erik Hooijberg, Annegien Broeks, Charlotte L Zuur, Bas W G van Rhijn, Daniel J Vis, Michiel S Van Der Heijden, Lodewyk F A Wessels
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors. Nature communications 15 (1) (2024)
Maud Rijnders, José Alberto Nakauma-González, Debbie G J Robbrecht, Alberto Gil-Jimenez, Hayri E Balcioglu, Astrid A M Oostvogels, Maureen J B Aarts, Joost L Boormans, Paul Hamberg, Michiel S Van Der Heijden, Bernadett E Szabados, G J L H Geert van Leenders, Niven Mehra, Jens Voortman, Hans M Westgeest, Ronald de Wit, Astrid A M van der Veldt, Reno Debets, Martijn Paul Lolkema
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer. Nature communications 15 (1) (2024)
Hielke Martijn de Vries, Tynisha S Rafael, Alberto Gil-Jimenez, Jeantine M de Feijter, Elise Bekers, Elsbeth van der Laan, Marta Lopez-Yurda, Erik Hooijberg, Annegien Broeks, Dennis Peters, Iris M Seignette, Floris J Pos, Simon Horenblas, Bas W G van Rhijn, Ekaterina S Jordanova, Oscar R Brouwer, Eva Schaake, Michiel S Van Der Heijden
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Nick van Dijk, Alberto Gil-Jimenez, Karina Silina, Kees Hendricksen, Laura A Smit, Jeantine M de Feijter, Maurits L van Montfoort, Charlotte van Rooijen, Dennis Peters, Annegien Broeks, Henk G van der Poel, Annemarie Bruining, Yoni Lubeck, Karolina Sikorska, Thierry N Boellaard, Pia Kvistborg, Daniel J Vis, Erik Hooijberg, Ton N M Schumacher, Maries van den Broek, Lodewyk F A Wessels, Christian U Blank, Bas W van Rhijn, Michiel S Van Der Heijden
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial. Nature medicine 26 (12) (2020)

Alberto Gil-Jimenez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alberto Gil-Jimenez